Antischistosomal drugs: past, present ... and future?

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Pharmacology and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0163-7258(95)00026-7PMID 8604437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Fluorometric method for the determination of praziquantel in blood-plasma and urine

  2010cited by this paper
• Quantitative determination of praziquantel in body fluids by gas liquid chromatography

  2010cited by this paper
• Chemistry of metrifonate and dichlorvos.

  2009cited by this paper
• Therapeutic properties of metrifonate.

  2009cited by this paper
• Guanine N7-alkylation in mice in vivo by metrifonate - discussion of possible genotoxic risk in mammals.

  2009cited by this paper
• Levels of metrifonate and dichlorvos in plasma and erythrocytes during treatment of schistosomiasis with Bilarcil.

  2009cited by this paper
• Esterases in schistosomes: reaction with substrates and inhibitors.

  2009cited by this paper
• Chemoprotective Effects of Two Dithiolthiones and of Butylhydroxyanisole Against Carbon Tetrachloride and Acetaminophen Toxicity

  2007cited by this paper
• Schistosoma mansoni: The effects of a subcurative dose of praziquantel on the ultrastructure of worms in vivo

  2004cited by this paper
• Effect of oltipraz on the susceptibility of adultSchistosoma mansoni to killing by mouse peritoneal exudate cells

  2004cited by this paper
• The relationship between tegumental disruption and muscle contraction inSchistosoma mansoni exposed to various compounds

  2004cited by this paper
• Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite onSchistosoma mansoni in vitro

  2004cited by this paper
• Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam

  2004cited by this paper
• Chlorpromazine, other amphiphilic cationic drugs and praziquantel: effects on carbohydrate metabolism ofSchistosoma mansoni

  2004cited by this paper
• Praziquantel impairs the ability of exogenous serotonin to stimulate carbohydrate metabolism in intact Schistosoma mansoni

  2004cited by this paper
• Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.

  1995cited by this paper
• Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

  1995cited by this paper
• Evaluation of the carcinogenic and genotoxic potential of praziquantel in the Syrian hamster embryo cell transformation assay.

  1994cited by this paper
• Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones.

  1994cited by this paper
• Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz.

  1994cited by this paper
• Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel.

  1994cited by this paper
• Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.

  1994cited by this paper
• Praziquantel (antischistosomal drug): is it clastogenic, co-clastogenic or anticlastogenic?

  1994cited by this paper
• Chemopreventive drug development: perspectives and progress.

  1994cited by this paper
• Cloning and characterization of a cDNA encoding phosphofructokinase from Schistosoma mansoni.

  1994cited by this paper
• The amount of acetylcholinesterase on the parasite surface reflects the differential sensitivity of schistosome species to metrifonate

  1994cited by this paper
• Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

  1994cited by this paper
• Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.

  1993cited by this paper
• Schistosoma: a 200-kDa chemotherapeutic target antigen is differentially localized in African vs Oriental species.

  1993cited by this paper
• Reduction in chromosomal damage in schistosomiasis patients after treatment with praziquantel.

  1993cited by this paper
• Drug resistance in schistosomes.

  1993cited by this paper
• Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.

  1993cited by this paper
• Oltipraz: A laboratory and clinical review

  1993cited by this paper
• Transdermal patch delivery of acetylcholinesterase inhibitors.

  1993cited by this paper
• [Treatment of bilharziasis].

  1993cited by this paper
• Antischistosomal drugs and clinical practice.

  1993cited by this paper
• Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules.

  1992cited by this paper
• Schistosoma mansoni: praziquantel-induced tegumental lesion exposes actin of surface spines and allows binding of actin depolymerizing factor, gelsolin

  1992cited by this paper
• Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene.

  1992cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992cited by this paper
• Cyclophilin of Schistosoma japonicum.

  1992cited by this paper
• Praziquantel: The enigmatic antiparasitic.

  1992cited by this paper
• High-performance liquid chromatographic determination of the stereoselective biotransformation of the chiral drug praziquantel.

  1992cited by this paper
• Mechanisms of inactivation of Schistosoma mansoni and mammalian glutathione S-transferase activity by the antischistosomal drug oltipraz.

  1992cited by this paper
• Cyclophilin of Schistosoma japonicum.

  1992cited by this paper
• Preferential inhibition of acetylcholinesterase molecular forms in rat brain

  1992cited by this paper
• The use of essential drugs. Model list of essential drugs (seventh list). Fifth report of the WHO Expert Committee.

  1992cited by this paper
• Selective release of a glycosylphosphatidylinositol-anchored antigen from the surface of Schistosoma mansoni.

  1991cited by this paper
• The larvicidal activity of cyclosporin A against Schistosoma mansoni in mice

  1991cited by this paper
• 抗住血吸虫症薬の遺伝毒性と発癌性の総説 突然変異疫学研究の一例となるか 変異原性抗住血吸虫症薬に関する作業部会報告

  1991cited by this paper
• Differential effects of oltipraz and its oxy-analogue on the viability of Schistosoma mansoni and the activity of glutathione S-transferase.

  1991cited by this paper
• Oxamniquine pharmacokinetics in healthy Kenyan African volunteers.

  1991cited by this paper
• The schistosomicidal compound Ro 15-5458 causes a reduction in the RNA content of Schistosoma mansoni.

  1991cited by this paper
• Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 5'-monophosphate against chronic and advanced stages of schistosomiasis.

  1991cited by this paper
• Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica.

  1991cited by this paper
• Characterization of a programmed alteration in an 18S ribosomal gene that accompanies the experimental induction of drug resistance in Schistosoma mansoni.

  1991cited by this paper
• Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 5'-monophosphate against chronic and advanced stages of schistosomiasis

  1991cited by this paper
• WHO Model Prescribing Information, Drugs Used in Parasitic Diseases

  1991cited by this paper
• International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.

  1991cited by this paper
• Genomic variability in field populations of Schistosoma mansoni in Brazil as detected with a ribosomal gene probe.

  1991cited by this paper
• Toward an understanding of the schistosomicidal effect of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz).

  1991cited by this paper
• Pharmacokinetics of metrifonate and its rearrangement product dichlorvos in whole blood.

  1991cited by this paper
• Schistosoma mansoni: preclinical studies with 9-Acridanone-hydrazones in Cebus monkeys experimentally infected.

  1991cited by this paper
• The apparent absorption kinetics of Ro 15-5458, a schistosomicidal drug.

  1990cited by this paper
• Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel

  1990cited by this paper
• Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis.

  1990cited by this paper
• Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effects.

  1990cited by this paper
• Metabolism of oltipraz and glutathione reductase inhibition.

  1990cited by this paper
• Failure to induce resistance of Schistosoma japonicum to praziquantel.

  1990cited by this paper
• Mode of action of the schistosomicide hycanthone: site of DNA alkylation.

  1990cited by this paper
• Schistosoma mansoni: biochemical characteristics of the antischistosomal effects of Ro 15-5458.

  1990cited by this paper
• Metabolism studies of the antischistosomal drug praziquantel using tandem mass spectrometry: distribution of parent drug and ten metabolites obtained from control and schistosome-infected mouse urine.

  1990cited by this paper
• Identification and characterization of glycosylphosphatidylinositol-linked Schistosoma mansoni adult worm immunogens.

  1990cited by this paper
• Binding of oxamniquine to the DNA of schistosomes.

  1989cited by this paper
• Early years of the salmonella mutagen tester strains: Lessons from hycanthone

  1989cited by this paper
• Glutathione redox state, lipid peroxide levels, and activities of glutathione enzymes in oltipraz-treated adult Schistosoma mansoni.

  1989cited by this paper
• Efficacy of a new Hoffmann-La Roche compound (Ro 15-5458) against Schistosoma mansoni (Gezira strain, Sudan) in vervet monkeys (Cercopithecus aethiops).

  1989cited by this paper
• Anti-schistosomal activity of cyclosporin A: studies on murine spleen cells and the influence of a cyclosporin antagonist on resistance to infection.

  1989cited by this paper
• Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.

  1989cited by this paper
• Enhancement of benzene clastogenicity by praziquantel in mice.

  1989cited by this paper
• Studies of mechanisms of niridazole-elicited embryotoxicity: evidence against a major role for covalent binding.

  1989cited by this paper
• A genomic change associated with the development of resistance to hycanthone in Schistosoma mansoni.

  1989cited by this paper
• Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni.

  1989cited by this paper
• Influence of praziquantel and Ca2+ on the bilayer-isotropic-hexagonal transition of model membranes.

  1988cited by this paper
• Preparation and antischistosomal and antitumor activity of hycanthone and some of its congeners. Evidence for the mode of action of hycanthone.

  1988cited by this paper
• Schistosoma mansoni: praziquantel-induced changes to the female reproductive system.

  1988cited by this paper
• Mode of insertion of praziquantel and derivatives into lipid membranes.

  1988cited by this paper
• Studies on some derivatives of oxamniquine.

  1988cited by this paper
• Binding of tritiated hycanthone and hycanthone N-methylcarbamate to macromolecules of drug-sensitive and drug-resistant schistosomes.

  1988cited by this paper
• Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.

  1988cited by this paper
• Studies on the action of cyclosporine A against Schistosoma mansoni and other parasitic infections.

  1988cited by this paper
• Parasitological evaluation of curative and subcurative doses of 9-acridanone-hydrazone drugs against Schistosoma mansoni in baboons, and observations on changes in serum levels of anti-egg antibodies detected by ELISA.

  1987cited by this paper
• Acute schistosomiasis (Katayama fever): clinical deterioration after chemotherapy.

  1987cited by this paper
• A review of clinical experience with oxamniquine.

  1987cited by this paper
• Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.

  1987cited by this paper
• New anthelmintics.

  1987cited by this paper
• The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response.

  1987cited by this paper
• Praziquantel in acute schistosomiasis.

  1987cited by this paper
• The diagnosis and treatment of acute toxaemic schistosomiasis in children.

  1987cited by this paper
• Enzymatic differences between hycanthone-resistant and sensitive strains of Schistosoma mansoni.

  1987cited by this paper

• A genome-scale drug discovery pipeline uncovers new therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoni

  2025cites this paper
• Development of a Novel Compound Effective Against Juvenile, Adult, and Drug-Resistant Schistosoma Species

  2025cites this paper
• Benzodeazaoxaflavin Sirtuin Inhibitors Inhibit Schistosoma mansoni Sirt2 and Cause Phenotypic Changes and Lethality in Schistosomula and Adult Worm Stages

  2025cites this paper
• The antifibrotic effect of Vildagliptin and Diaminodiphenyl Sulfone in murine schistosomiasis mansoni

  2025cites this paper
• A genome-scale drug discovery pipeline uncovers therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoni

  2025cites this paper
• Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of

  2025cites this paper
• Current perspectives in the epidemiology and control of lymphatic filariasis

  2025cites this paper
• Therapeutic and vaccinomic potential of moonlighting proteins for the discovery and design of drugs and vaccines against schistosomiasis.

  2024cites this paper
• Robenidine derivatives as potential antischistosomal drug candidates

  2024cites this paper
• GNN‐DDAS: Drug discovery for identifying anti‐schistosome small molecules based on graph neural network

  2024cites this paper
• Nanotechnological approaches in the treatment of schistosomiasis: an overview

  2024cites this paper
• Current Advances in Synthesis and Therapeutic Applications of Pyrimidine

  2024cites this paper
• Oxamniquine Derivatives Overcome Praziquantel Treatment Limitations for Schistosomiasis

  2023cites this paper
• Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis

  2023cites this paper
• The long road to schistosomiasis elimination in Zanzibar: A systematic review covering 100 years of research, interventions and control milestones.

  2023cites this paper
• Expression profile analysis of the transient receptor potential (TRPM) channel, a possible target of praziquantel in Schistosoma japonicum.

  2023cites this paper
• Docking-Based Virtual Screening Enables Prioritizing Protein Kinase Inhibitors With In Vitro Phenotypic Activity Against Schistosoma mansoni

  2022cites this paper
• Praziquantel: an update on the mechanism of its action against schistosomiasis and new therapeutic perspectives.

  2022cites this paper
• The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models

  2022cites this paper
• Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs

  2021cites this paper
• Tetracyclic Thioxanthene Derivatives: Studies on Fluorescence and Antitumor Activity

  2021cites this paper
• Bioorganometallic Compounds as Novel Drug Targets against Schistosomiasis in Sub-Saharan Africa: An alternative to Praziquantel?

  2021cites this paper
• Anti-Schistosomal Activity of Medicinal Plants: Mini Review

  2021cites this paper
• From Natural Products to New Synthetic Small Molecules: A Journey through the World of Xanthones

  2021cites this paper
• Experimental treatment of Schistosomiasis mansoni using praziquantel-free and encapsulated into nanostructures

  2021cites this paper
• Rational approach to drug discovery for human schistosomiasis

  2021cites this paper
• Cloning and functional complementation of ten Schistosoma mansoni phosphodiesterases expressed in the mammalian host stages

  2020cites this paper
• Molecular basis of inhibition of Schistosoma japonicum glutathione transferase by ellagic acid: insights into biophysical and structural studies.

  2020cites this paper
• Botanical Products in the Treatment and Control of Schistosomiasis: Recent Studies and Distribution of Active Plant Resources According to Affected Regions

  2020cites this paper
• Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?

  2020cites this paper
• Antiparasitic effects of ethanolic extracts of Piper arboreum and Jatropha gossypiifolia leaves on cercariae and adult worms of Schistosoma mansoni

  2020cites this paper
• Computer-Aided Drug Design for the Identification of Novel Antischistosomal Compounds.

  2020cites this paper
• An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans

  2020cites this paper
• Schistosomiasis then and now: what has changed in the last 100 years?

  2020cites this paper
• Praziquantel: An Enigmatic, Yet Effective, Drug.

  2020cites this paper
• Quinolizidine-Derived Lucanthone and Amitriptyline Analogues Endowed with Potent Antileishmanial Activity

  2020cites this paper
• In Situ Incorporation of Praziquantel in Polymer Microparticles through Suspension Polymerization for Treatment of Schistosomiasis

  2019cites this paper
• The efficacy of fenbendazole against tapeworm infections in the common carp (Cyprinus carpio L.) in Veľké Blahovo ponds

  2019cites this paper
• PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?

  2019cites this paper
• New Insights into the Treatment of Foodborne Trematode Infections

  2019cites this paper
• Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.

  2019cites this paper
• FLAVONOIDES E CURCUMINOIDES – POTENCIAIS ALTERNATIVAS TERAPÊUTICAS PARA ESQUISTOSSOMOSE: UMA REVISÃO BIBLIOGRÁFICA

  2019cites this paper
• Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal Agents.

  2018cites this paper
• Targeting thioredoxin glutathione reductase as a potential antischistosomal drug target.

  2018cites this paper
• Nanomedicine Approaches Against Parasitic Worm Infections

  2018cites this paper
• Chemotherapy for Fighting Schistosomiasis: Past, Present and Future

  2018cites this paper
• Antischistosomal agents: state of art and perspectives.

  2018cites this paper
• Chiral Thioxanthones as Modulators of P-glycoprotein: Synthesis and Enantioselectivity Studies

  2018cites this paper
• HAEMATOBIUM INFECTION AND DRUG TREATMENT ON THE IMMUNE SYSTEM OF IMMUNOSUPPRESSED GUINEA PIGS * 1

  2018cites this paper
• Conformational polymorphic changes in the crystal structure of the chiral antiparasitic drug praziquantel and interactions with calcium carbonate

  2018cites this paper
• Sterculia and Brachychiton: a comprehensive overview on their ethnopharmacology, biological activities, phytochemistry and the role of their gummy exudates in drug delivery

  2018cites this paper
• Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates.

  2018cites this paper
• The mechanism of action of praziquantel: can new drugs exploit similar mechanisms?

  2018cites this paper
• Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies

  2018cites this paper
• Antischistosomal and Immune Enhancing Potential of Azadirachta Indica and Ekebergia Capensis in Mice Infected with Schistosoma Mansoni

  2017influential citation
• Akt signalling in the human parasite 'Schistosoma mansoni'

  2017cites this paper
• Identifying a role for heat shock proteins in Schistosoma mansoni

  2017cites this paper
• Dihydrobenz[e][1,4]oxazepin-2(3H)-ones, a new anthelmintic chemotype immobilising whipworm and reducing infectivity in vivo

  2017cites this paper
• Chemotherapy and Drug Resistance in Schistosomiasis and Other Trematode and Cestode Infections

  2017cites this paper
• Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance

  2017cites this paper
• Synthesis and biological evaluation of novel imidazolinic, thiazolinic derivatives and aminosugars

  2017influential citation
• The anthelminthic drug praziquantel is a selective agonist of the sensory transient receptor potential melastatin type 8 channel

  2017cites this paper
• Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.

  2017cites this paper
• Cyclohexene-fused 1,3-oxazines with selective antibacterial and antiparasitic action and low cytotoxic effects.

  2017cites this paper
• A palladium-catalyzed intramolecular Heck/Hydrogenation approach towards the synthesis of praziquantel

  2017cites this paper
• Photodynamic therapy for Schistosoma mansoni: Promising outcomes.

  2017cites this paper
• Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy

  2017cites this paper
• The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases

  2016cites this paper
• Molecular and crystal structure of praziquantel. Spectroscopic properties and crystal polymorphism.

  2016cites this paper
• Neglected Tropical Diseases - Sub-Saharan Africa

  2016cites this paper
• Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia

  2016cites this paper
• Small Chiral Molecules Modulators of P-gp: Synthesis and Studies of Enantioselectivity

  2016cites this paper
• Toward organometallic antischistosomal drug candidates.

  2015cites this paper
• Synthesis and evaluation of new 3-substituted-4-chloro-thioxanthone derivatives as potent anti-breast cancer agents

  2015cites this paper
• Recent therapeutic approaches in control of parasitic diseases with special reference to schistosomiasis

  2015cites this paper
• Potent Schistosomicidal Constituents from Garcinia brasiliensis

  2015cites this paper
• Degradation rate of praziquantel and fenbendazole in rainbow trout following oral administration.

  2015cites this paper
• Structure-function analysis of apical membrane-linked molecules for treatment and control of schistosome parasites of humans : insights from studies into annexins

  2015cites this paper
• Phenolics and Terpenoids; the Promising New Search for Anthelmintics: A Critical Review.

  2015cites this paper
• Structure–function analysis of apical membrane‐associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control

  2015cites this paper
• Anthelmintic Activity In Vivo of Epiisopiloturine against Juvenile and Adult Worms of Schistosoma mansoni

  2015cites this paper
• Natural products with antischistosomal activity.

  2015cites this paper
• Furofuran lignans display schistosomicidal and trypanocidal activities.

  2014cites this paper
• Drugs for treating urinary schistosomiasis

  2014cites this paper
• Chromatographic Fingerprint Analysis and Effects of the Medicinal Plant Species Mitracarpus frigidus on Adult Schistosoma mansoni Worms

  2014cites this paper
• Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel.

  2014cites this paper
• Tetrasubstituted pyrazinones derived from the reaction of praziquantel with N-bromosuccinimide.

  2014cites this paper
• Schistosoma mansoni susceptibility to praziquantel in endemic localities in Kenya

  2014cites this paper
• Praziquantel: a review.

  2014cites this paper
• Molecular & Biochemical Parasitology

  2014cites this paper
• Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race.

  2014cites this paper
• Schistosomiasis control: praziquantel forever?

  2014cites this paper
• Praziquantel Treatment Decreases Schistosoma mansoni Genetic Diversity in Experimental Infections

  2013cites this paper
• Evaluation of praziquantel effects on Echinostoma paraensei ultrastructure.

  2013cites this paper
• Natural Products as a Source for Treating Neglected Parasitic Diseases

  2013cites this paper
• TEGUMENTARY CHANGES IN TWO DIFFERENT STRAINS OF Schistosoma mansoni TREATED WITH ARTEMISININ AND ARTESUNIC ACID

  2013cites this paper
• The evolution of drugs on schistosoma treatment: looking to the past to improve the future.

  2013influential citation
• Medicinal plants and their bioactive constituents: A review of bioactivity against Schistosoma mansoni

  2013cites this paper
• Drugs for treating Schistosoma mansoni infection.

  2013cites this paper
• A century of thioxanthones: through synthesis and biological applications.

  2013cites this paper